203 related articles for article (PubMed ID: 29359615)
1. Correlation of Inflammatory Markers, Survival, and COX2 Expression in Oral Cancer and Implications for Prognosis.
Sano Y; Kogashiwa Y; Araki R; Enoki Y; Ikeda T; Yoda T; Nakahira M; Sugasawa M
Otolaryngol Head Neck Surg; 2018 Apr; 158(4):667-676. PubMed ID: 29359615
[TBL] [Abstract][Full Text] [Related]
2. Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma.
Grimm M; Rieth J; Hoefert S; Krimmel M; Rieth S; Teriete P; Kluba S; Biegner T; Munz A; Reinert S
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3371-84. PubMed ID: 26926692
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.
Xie X; Luo KJ; Hu Y; Wang JY; Chen J
Dis Esophagus; 2016 Jan; 29(1):79-85. PubMed ID: 25410116
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of systemic inflammatory markers for oral cancer patients based on the 8th edition of AJCC staging system.
Lee S; Kim DW; Kwon S; Kim HJ; Cha IH; Nam W
Sci Rep; 2020 Jul; 10(1):12111. PubMed ID: 32694586
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.
Zhang Y; Jiang C; Li J; Sun J; Qu X
Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119
[TBL] [Abstract][Full Text] [Related]
6. Preoperative platelet lymphocyte ratio is superior to neutrophil lymphocyte ratio to be used as predictive marker for lymph node metastasis in oral squamous cell carcinoma.
Acharya S; Rai P; Hallikeri K; Anehosur V; Kale J
J Investig Clin Dent; 2017 Aug; 8(3):. PubMed ID: 27157628
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Neutrophil-to-Lymphocyte Ratio Predicts the Prognosis of Oral Squamous Cell Carcinoma: A Large-Sample Prospective Study.
Chen F; Lin L; Yan L; Qiu Y; Cai L; He B
J Oral Maxillofac Surg; 2017 Jun; 75(6):1275-1282. PubMed ID: 28011326
[TBL] [Abstract][Full Text] [Related]
8. Comparative prognostic value of different preoperative complete blood count cell ratios in patients with oral cavity cancer treated with surgery and postoperative radiotherapy.
Wu YY; Chang KP; Ho TY; Chou WC; Hung SP; Fan KH; Chiang YY; Chou YC; Tsang NM
Cancer Med; 2021 Mar; 10(6):1975-1988. PubMed ID: 33624454
[TBL] [Abstract][Full Text] [Related]
9. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
10. The effect of preoperative neutrophil, platelet and lymphocyte counts on local recurrence and survival in early-stage tongue cancer.
Ozturk K; Akyildiz NS; Uslu M; Gode S; Uluoz U
Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4425-4429. PubMed ID: 27188509
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.
Turri-Zanoni M; Salzano G; Lambertoni A; Giovannardi M; Karligkiotis A; Battaglia P; Castelnuovo P
Head Neck; 2017 Apr; 39(4):730-736. PubMed ID: 28032937
[TBL] [Abstract][Full Text] [Related]
12. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
[TBL] [Abstract][Full Text] [Related]
13. Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study.
Nakashima H; Matsuoka Y; Yoshida R; Nagata M; Hirosue A; Kawahara K; Sakata J; Arita H; Hiraki A; Nakayama H
BMC Cancer; 2016 Jan; 16():41. PubMed ID: 26812901
[TBL] [Abstract][Full Text] [Related]
14. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma.
Rassouli A; Saliba J; Castano R; Hier M; Zeitouni AG
Head Neck; 2015 Jan; 37(1):103-10. PubMed ID: 24339165
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
16. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery.
Zhang Y; Wang L; Liu Y; Wang S; Shang P; Gao Y; Chen X
Int J Gynecol Cancer; 2014 Sep; 24(7):1319-25. PubMed ID: 25033256
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Performance of a New Staging Category to Improve Discrimination of Disease-Specific Survival in Nonmetastatic Oral Cancer.
Lee CC; Huang CY; Lin YS; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; Chen HC; Yang CC
JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):395-402. PubMed ID: 28125757
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of preoperative systemic inflammatory markers in oral squamous cell carcinoma, and correlations with the local immune tumor microenvironment.
Ruiz-Ranz M; Lequerica-Fernández P; Rodríguez-Santamarta T; Suárez-Sánchez FJ; López-Pintor RM; García-Pedrero JM; de Vicente JC
Front Immunol; 2022; 13():941351. PubMed ID: 35958590
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of the prognostic value of the neutrophil-to-lymphocyte ratio in oral squamous cell carcinoma.
Wang Y; Wang P; Andrukhov O; Wang T; Song S; Yan C; Zhang F
J Oral Pathol Med; 2018 Apr; 47(4):353-358. PubMed ID: 29406591
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
